Singh, S., & Kaur, K. Initial Data on Clinical Use of Generic Romiplostim for Second-Line and Subsequent Therapy of Immune Thrombocytopenia in India. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationSingh, Suvir, and Komalpreet Kaur. Initial Data on Clinical Use of Generic Romiplostim for Second-Line and Subsequent Therapy of Immune Thrombocytopenia in India. Wolters Kluwer Medknow Publications.
MLA (9th ed.) CitationSingh, Suvir, and Komalpreet Kaur. Initial Data on Clinical Use of Generic Romiplostim for Second-Line and Subsequent Therapy of Immune Thrombocytopenia in India. Wolters Kluwer Medknow Publications.
Warning: These citations may not always be 100% accurate.